- Conditions
- Osteoarthritis
- Interventions
- Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20
- Drug
- Lead sponsor
- UConn Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Farmington, Connecticut
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 284
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Osteoarthritis, Knee
- Interventions
- Placebo, CNTX-4975-05
- Drug
- Lead sponsor
- Centrexion Therapeutics
- Industry
- Eligibility
- 40 Years to 95 Years
- Enrollment
- 332 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 30
- States / cities
- Glendale, Arizona • Phoenix, Arizona • Carmichael, California + 23 more
- Conditions
- Degenerative Sacroiliitis, Sacroiliac Joint Disruption
- Interventions
- iFuse Implant System, Non-surgical management
- Device · Other
- Lead sponsor
- SI-BONE, Inc.
- Industry
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 159 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 19
- States / cities
- La Jolla, California • Newport Beach, California • Denver, Colorado + 16 more
- Conditions
- Knee Arthritis Osteoarthritis
- Interventions
- Triamcinolone knee injection without ultrasound guidance, Triamcinolone knee injection with ultrasound guidance
- Drug · Combination Product
- Lead sponsor
- Sosi Dzhugarian
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 4
- States / cities
- Ventura, California
- Conditions
- Osteoarthritis Post-meniscectomy
- Interventions
- Bone Marrow Aspirate Concentrate, Standard Meniscectomy
- Biological · Procedure
- Lead sponsor
- Rush University Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2026
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Knee Osteoarthritis
- Interventions
- Ketorolac, Betamethasone
- Drug
- Lead sponsor
- St. Luke's Hospital, Pennsylvania
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 448 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Bethlehem, Pennsylvania
- Conditions
- Knee Osteoarthritis
- Interventions
- Durolane, PBS
- Device
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 25
- States / cities
- Anniston, Alabama • Mobile, Alabama • Phoenix, Arizona + 22 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- MISHA Knee System, Non-Surgical Treatment
- Device · Other
- Lead sponsor
- Moximed
- Industry
- Eligibility
- Not listed
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 9
- States / cities
- Davis, California • Oceanside, California • Sacramento, California + 6 more
- Conditions
- Osteoarthritis of the Knee
- Interventions
- FX006 10 mg, FX006 40 mg, TCA IR 40 mg
- Drug
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 3
- States / cities
- Paducah, Kentucky • Duncansville, Pennsylvania • Dallas, Texas
- Conditions
- Arthritis, Osteo Arthritis of the Knee
- Interventions
- Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, Intra articular injection
- Device · Drug
- Lead sponsor
- ZetrOZ, Inc.
- Industry
- Eligibility
- 65 Years to 85 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2028
- U.S. locations
- 2
- States / cities
- Stamford, Connecticut • Dryden, New York
- Conditions
- Osteoarthritis of the Knee
- Interventions
- 4 mL injection of Ampion, 4 mL injection of Placebo
- Biological · Drug
- Lead sponsor
- Ampio Pharmaceuticals. Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Englewood, Colorado
- Conditions
- Lateral Epicondylitis
- Interventions
- Not listed
- Lead sponsor
- University of Missouri, Kansas City
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- Kansas City, Missouri
- Conditions
- SI Joint Pain
- Interventions
- 0.75% bupivacaine, .75% bupivacaine
- Drug
- Lead sponsor
- SI-BONE, Inc.
- Industry
- Eligibility
- 21 Years to 75 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 7
- States / cities
- Mount Vernon, Illinois • Lexington, Kentucky • Cleveland, Ohio + 4 more
- Conditions
- Total Knee Arthroplasty
- Interventions
- Peripheral nerve blocks with Bupivacaine, Intra articular injection with Ropivacaine, Intra articular injection with liposomal bupivacaine
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 165 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Hip Osteoarthritis
- Interventions
- PRP, Hyaluronic Acid
- Biological · Device
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 30 Years to 72 Years
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2019
- U.S. locations
- 1
- States / cities
- Boulder, Colorado
- Conditions
- Platelet-Rich Plasma (PRP), Knee Osteoarthritis (OA)
- Interventions
- Intra-Articular knee injection of LC-PRP
- Procedure
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Osteoarthritis
- Interventions
- Liposuction with Local Anesthesia, Intra articular infusion of AD-SVF
- Procedure · Biological
- Lead sponsor
- Ageless Regenerative Institute
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Aventura, Florida
- Conditions
- Osteoarthritis, Hip
- Interventions
- Synvisc-One (hylan G-F 20), Placebo
- Device
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 35 Years and older
- Enrollment
- 357 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 45
- States / cities
- Burmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 41 more
- Conditions
- Knee Osteoarthritis
- Interventions
- HYMOVIS, Placebo
- Device
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 332 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 21
- States / cities
- Birmingham, Alabama • Brimingham, Alabama • Phoenix, Arizona + 17 more
- Conditions
- Osteoarthritis
- Interventions
- RTX-GRT7039, Placebo
- Drug
- Lead sponsor
- Grünenthal GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 466 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 56
- States / cities
- Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 42 more
- Conditions
- Osteoarthritis (OA) of the Knee
- Interventions
- Neural Ice, Triamcinolone acetate
- Device · Drug
- Lead sponsor
- Brixton Biosciences, Inc.
- Industry
- Eligibility
- 22 Years to 80 Years
- Enrollment
- 263 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 15
- States / cities
- Larkspur, California • Washington D.C., District of Columbia • Gainesville, Florida + 12 more
- Conditions
- Femoroacetabular Impingement, Chondral Lesions
- Interventions
- Platelet-rich plasma (PRP), Saline
- Biological · Drug
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 18 Years to 50 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Boulder, Colorado
- Conditions
- Osteoarthritis, Post-traumatic; Arthrosis
- Interventions
- methylprednisolone acetate, active comparator
- Drug
- Lead sponsor
- New Lexington Clinic
- Other
- Eligibility
- 18 Years to 95 Years
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Low Back Pain, Sacroiliac Joint Synovitis
- Interventions
- Sacroiliac intra-articular injection
- Procedure
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 2
- States / cities
- Salt Lake City, Utah